MBRX Annual Net Income
-$29.77 M
-$744.00 K-2.56%
31 December 2023
Summary:
As of January 20, 2025, MBRX annual net profit is -$29.77 million, with the most recent change of -$744.00 thousand (-2.56%) on December 31, 2023. During the last 3 years, it has fallen by -$12.41 million (-71.53%). MBRX annual net income is now -658.25% below its all-time high of -$3.93 million, reached on December 31, 2016.MBRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX Quarterly Net Income
-$10.59 M
-$6.27 M-145.24%
30 September 2024
Summary:
As of January 20, 2025, MBRX quarterly net profit is -$10.59 million, with the most recent change of -$6.27 million (-145.24%) on September 30, 2024. Over the past year, it has dropped by -$5.62 million (-113.12%). MBRX quarterly net income is now -3119.45% below its all-time high of -$329.00 thousand, reached on March 31, 2017.MBRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX TTM Net Income
-$30.15 M
-$4.98 M-19.80%
30 September 2024
Summary:
As of January 20, 2025, MBRX TTM net profit is -$30.15 million, with the most recent change of -$4.98 million (-19.80%) on September 30, 2024. Over the past year, it has dropped by -$3.33 million (-12.40%). MBRX TTM net income is now -8981.33% below its all-time high of -$332.00 thousand, reached on March 31, 2016.MBRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.6% | -113.1% | -12.4% |
| 3 y3 years | -71.5% | -77.2% | -3.0% |
| 5 y5 years | -150.7% | -77.2% | -3.0% |
MBRX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.3% | at low | -274.9% | at low | -89.7% | at low |
| 5 y | 5-year | -125.4% | at low | -776.1% | at low | -190.7% | at low |
| alltime | all time | -658.3% | at low | -3119.4% | at low | -8981.3% | at low |
Moleculin Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.59 M(+145.2%) | -$30.15 M(+19.8%) |
| June 2024 | - | -$4.32 M(-13.1%) | -$25.17 M(-6.2%) |
| Mar 2024 | - | -$4.97 M(-51.6%) | -$26.82 M(-9.9%) |
| Dec 2023 | -$29.77 M(+2.6%) | -$10.27 M(+83.1%) | -$29.77 M(+13.3%) |
| Sept 2023 | - | -$5.61 M(-6.1%) | -$26.27 M(-10.3%) |
| June 2023 | - | -$5.98 M(-24.5%) | -$29.27 M(-2.7%) |
| Mar 2023 | - | -$7.92 M(+16.9%) | -$30.07 M(+3.6%) |
| Dec 2022 | -$29.02 M(+82.6%) | -$6.77 M(-21.4%) | -$29.02 M(+15.7%) |
| Sept 2022 | - | -$8.61 M(+27.1%) | -$25.08 M(+20.3%) |
| June 2022 | - | -$6.78 M(-1.3%) | -$20.85 M(+13.8%) |
| Mar 2022 | - | -$6.87 M(+143.1%) | -$18.32 M(+15.2%) |
| Dec 2021 | -$15.89 M(-8.4%) | -$2.83 M(-35.5%) | -$15.89 M(+1.2%) |
| Sept 2021 | - | -$4.38 M(+3.2%) | -$15.71 M(+6.7%) |
| June 2021 | - | -$4.24 M(-4.5%) | -$14.72 M(-28.5%) |
| Mar 2021 | - | -$4.45 M(+68.4%) | -$20.59 M(+18.6%) |
| Dec 2020 | -$17.36 M | -$2.64 M(-22.3%) | -$17.36 M(-6.3%) |
| Sept 2020 | - | -$3.40 M(-66.4%) | -$18.51 M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$10.11 M(+736.4%) | -$19.26 M(+85.7%) |
| Mar 2020 | - | -$1.21 M(-68.2%) | -$10.37 M(-21.4%) |
| Dec 2019 | -$13.21 M(+11.2%) | -$3.80 M(-8.4%) | -$13.20 M(+8.3%) |
| Sept 2019 | - | -$4.14 M(+239.5%) | -$12.19 M(+20.9%) |
| June 2019 | - | -$1.22 M(-69.8%) | -$10.09 M(-27.9%) |
| Mar 2019 | - | -$4.04 M(+45.1%) | -$13.99 M(+17.8%) |
| Dec 2018 | -$11.88 M(+21.1%) | -$2.79 M(+36.7%) | -$11.88 M(-3.3%) |
| Sept 2018 | - | -$2.04 M(-60.2%) | -$12.28 M(-6.3%) |
| June 2018 | - | -$5.13 M(+166.0%) | -$13.10 M(+14.9%) |
| Mar 2018 | - | -$1.93 M(-39.5%) | -$11.40 M(+16.3%) |
| Dec 2017 | -$9.80 M(+149.7%) | -$3.19 M(+11.1%) | -$9.80 M(+21.9%) |
| Sept 2017 | - | -$2.87 M(-16.3%) | -$8.04 M(+21.7%) |
| June 2017 | - | -$3.42 M(+940.7%) | -$6.61 M(+68.4%) |
| Mar 2017 | - | -$329.00 K(-76.9%) | -$3.92 M(-0.1%) |
| Dec 2016 | -$3.93 M | -$1.42 M(-0.6%) | -$3.93 M(+56.9%) |
| Sept 2016 | - | -$1.43 M(+93.8%) | -$2.50 M(+133.7%) |
| June 2016 | - | -$739.00 K(+122.6%) | -$1.07 M(+222.6%) |
| Mar 2016 | - | -$332.00 K | -$332.00 K |
FAQ
- What is Moleculin Biotech annual net profit?
- What is the all time high annual net income for Moleculin Biotech?
- What is Moleculin Biotech annual net income year-on-year change?
- What is Moleculin Biotech quarterly net profit?
- What is the all time high quarterly net income for Moleculin Biotech?
- What is Moleculin Biotech quarterly net income year-on-year change?
- What is Moleculin Biotech TTM net profit?
- What is the all time high TTM net income for Moleculin Biotech?
- What is Moleculin Biotech TTM net income year-on-year change?
What is Moleculin Biotech annual net profit?
The current annual net income of MBRX is -$29.77 M
What is the all time high annual net income for Moleculin Biotech?
Moleculin Biotech all-time high annual net profit is -$3.93 M
What is Moleculin Biotech annual net income year-on-year change?
Over the past year, MBRX annual net profit has changed by -$744.00 K (-2.56%)
What is Moleculin Biotech quarterly net profit?
The current quarterly net income of MBRX is -$10.59 M
What is the all time high quarterly net income for Moleculin Biotech?
Moleculin Biotech all-time high quarterly net profit is -$329.00 K
What is Moleculin Biotech quarterly net income year-on-year change?
Over the past year, MBRX quarterly net profit has changed by -$5.62 M (-113.12%)
What is Moleculin Biotech TTM net profit?
The current TTM net income of MBRX is -$30.15 M
What is the all time high TTM net income for Moleculin Biotech?
Moleculin Biotech all-time high TTM net profit is -$332.00 K
What is Moleculin Biotech TTM net income year-on-year change?
Over the past year, MBRX TTM net profit has changed by -$3.33 M (-12.40%)